Records containing: Retinopathy of Prematurity (ROP)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase 1b, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of FLQ-101 in Premature Neonates at High Risk of Developing ROP
-
CLINICAL_TRIALS study record update · 2026-03-31Multicenter, Randomized, Double-Blind Pilot Clinical Trial Evaluating the Impact of Transfusion With Heterologous Cord Blood-Derived Red Blood Cells Versus Adult Red Blood Cells in Extremely Premature Infants
-
CLINICAL_TRIALS study record update · 2026-02-23Children Treated for Retinopathy of Prematurity - Study of Visual Function and Retinal Structure
-
CLINICAL_TRIALS study record update · 2026-01-07A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
-
CLINICAL_TRIALS study record update · 2025-12-31ROP Check Premature Infant Outcomes
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-10-10An Extension Study to Evaluate the Long-term Outcomes of Subjects Who Received Treatment for Retinopathy of Prematurity in Study 20090
-
CLINICAL_TRIALS study record update · 2025-08-14The Correlation Between Packed Red Blood Cell Transfusion and Early and Late Complications of Prematurity
-
CLINICAL_TRIALS study record update · 2025-08-08Intranasal Fentanyl to Reduce Pain Intensity Associated With Retinopathy of Prematurity Screening in Preterm Infants: A Randomized Control Trial
-
CLINICAL_TRIALS study record update · 2025-05-15Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
-
CLINICAL_TRIALS study record update · 2025-04-04Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy: A Multicenter, Prospective, Randomized, Double-blind, Non-inferiority Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-01-22The Effect of Dexamethasone Eye Drops on Retinopathy of Prematurity, a Swedish Registry-based Study
-
CLINICAL_TRIALS study record update · 2024-12-11A Multicenter and Prospective Study of Screening Retinopathy of Prematurity in China
-
CLINICAL_TRIALS study record update · 2024-11-19The Effect of Reverse Kangaroo Care Position and ROP Position on Pain During Retinopathy Examination in Premature Infants
-
CLINICAL_TRIALS study record update · 2024-10-18Long-term Ophthalmic Outcomes in Ex-premature Infants
-
CLINICAL_TRIALS study record update · 2023-03-24Long-Term Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
-
CLINICAL_TRIALS study record update · 2023-02-13RAINBOW Extension Study: an Extension Study to Evaluate the Long Term Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
-
CLINICAL_TRIALS study record update · 2022-05-06Open-label, Randomized, Two-Arm, Controlled Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal (IVT) Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity (ROP)
-
CLINICAL_TRIALS study record update · 2022-04-25Long-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated With rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal Care
-
CLINICAL_TRIALS study record update · 2018-09-26INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants
-
CLINICAL_TRIALS study record update · 2017-06-07Determination of the rhIGF-1/rhIGFBP-3 Dose, Administered as a Continuous Infusion, Required to Establish and Maintain Longitudinal Serum IGF-1 Levels Within Physiological Levels in Premature Infants, to Prevent Retinopathy of Prematurity A Phase 2, Randomized Controlled, Assessor-blind, Dose Confirming, Pharmacokinetic, Safety and Efficacy, Multicenter Study
-
CLINICAL_TRIALS study record update · 2017-03-09Multicenter Randomized Double Masked Parallel Design Exploratory Study to Assess Safety and Efficacy of Two Different Doses of Intravitreal Anti-VEGF Treatment With Ranibizumab (0.12 mg vs. 0.20 mg) in Infants With Retinopathy of Prematurity (ROP)
-
CLINICAL_TRIALS study record update · 2014-01-28Study to Measure Systemic VEGF Levels in ROP Infants Following Intravitreal Anti-VEGF Therapy or Retinal Laser Treatment
-
CLINICAL_TRIALS study record update · 2010-01-22A Randomized Controlled Trial to Determine the Lowest Effective Dose for Adequate Mydriasis in Premature Infants